Lincoln Pharmaceuticals Ltd Half Yearly Results

Gross Sales

314.73

308.5

288.94

291.61

246.23

Excise Duty

0

0

0

0

0

Net Sales

314.73

308.5

288.94

291.61

246.23

Other Operating Income

0

0

0

0

0

Other Income

2.09

20.39

18.04

16.39

10.26

Total Income

316.83

328.88

306.98

307.99

256.48

Total Expenditure

264.35

257.38

240.9

239.74

202.84

PBIDT

52.47

71.5

66.08

68.25

53.65

Interest

1.09

0.79

0.65

0.81

1.48

PBDT

51.38

70.71

65.43

67.44

52.17

Depreciation

6.45

6.45

5.5

5.13

4.68

Minority Interest Before NP

0

0

0

0

0

Tax

14.7

10.63

11.32

14.12

11.87

Deferred Tax

-2.11

3.63

1.97

1.53

1.45

Reported Profit After Tax

32.34

50

46.64

46.67

34.17

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

32.34

50

46.64

46.67

34.17

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

32.34

50

46.64

46.67

34.17

EPS (Unit Curr.)

16.15

24.96

23.29

23.3

17.06

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

20.03

20.03

20.03

20.03

20.03

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.67

23.17

22.86

23.4

21.78

PBDTM(%)

-

-

-

-

-

PATM(%)

10.27

16.2

16.14

16

13.87